Affimed, J&J deal

Affimed's Amphivena Therapeutics Inc. subsidiary in the U.S. granted Johnson & Johnson's Janssen Biotech Inc. subsidiary an exclusive option to acquire Amphivena following an IND approval by FDA or ma...